<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Should you treat preclinical canine MMVD with ACEIs?</title><link>/b/veterinary-news/posts/should-you-treat-preclinical-canine-mmvd-with-aceis</link><description> According to a review published in the May edition of the Journal of Small Animal Practice , administration of ACEIs to dogs with preclinical MMVD and cardiomegaly results in little or no difference in the risk of developing congestive heart failure</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>